Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year.
Agilent Technologies's 1-Year ROIIC % for the quarter that ended in Apr. 2026 was 33.33%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Agilent Technologies's 1-Year ROIIC % or its related term are showing as below:
MEX:A's 1-Year ROIIC % is ranked better than 71.84% of 206
companies
in the Medical Diagnostics & Research industry
Industry Median: 3.17
vs MEX:A: 33.33
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Agilent Technologies 1-Year ROIIC % Related Terms
Agilent Technologies 1-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Agilent Technologies's 1-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:A vs NTRA, WAT, IDXX: 1-Year ROIIC % Comparison
For the Diagnostics & Research subindustry, Agilent Technologies's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agilent Technologies 1-Year ROIIC % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Agilent Technologies's 1-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Agilent Technologies's 1-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Agilent Technologies (MEX:A) has a 1-Year ROIIC % of 33.33 as of Apr. 2026. 1-Year ROIIC % measures the change in earnings as a percentage of change in investment over 1-year. View historical data on Agilent Technologies and its competitors. According to the industry distribution chart, Agilent Technologies ranks #58 out of 206 companies in the Medical Diagnostics & Research industry, placing it in the top 28.2%.
Is Agilent Technologies' 1-Year ROIIC % too high?
Agilent Technologies' current 1-Year ROIIC % is 33.33. The Medical Diagnostics & Research industry median 1-Year ROIIC % is 3.17. Agilent Technologies' value of 33.33 is 951.4% above this industry median. Based on the distribution chart, Agilent Technologies ranks #58 out of 206 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Agilent Technologies has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Agilent Technologies' 1-Year ROIIC % compare to NTRA and WAT?
According to the Medical Diagnostics & Research industry distribution chart, Agilent Technologies ranks #58 out of 206 companies for 1-Year ROIIC %. This puts Agilent Technologies in the upper half of its industry. The industry median 1-Year ROIIC % is 3.17. Agilent Technologies' value of 33.33 is 951.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year ROIIC % for a Medical Diagnostics & Research company?
The median 1-Year ROIIC % among Medical Diagnostics & Research companies is 3.17, based on 206 companies in the industry. Companies in the top quartile (top 25%) have a 1-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 1-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Agilent Technologies's current 1-Year ROIIC % of 33.33 is 951.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year ROIIC % mean?
A high 1-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 1-Year ROIIC % measures the change in earnings as a percentage of change in investment over 1-year. View historical data on Agilent Technologies and its competitors. For the Medical Diagnostics & Research industry, the median 1-Year ROIIC % is 3.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Agilent Technologies's current 1-Year ROIIC % is 33.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilent Technologies stock overvalued right now?
Based on GuruFocus' analysis, Agilent Technologies (MEX:A) is currently considered Fairly Valued. The stock's GF Value™ is MXN2,557.40, compared to a current price of MXN2,350.00 — trading 8.1% below its estimated fair value. The current 1-Year ROIIC % is 33.33 and 951.4% above the Medical Diagnostics & Research industry median of 3.17. Agilent Technologies' overall GF Score™ is 89/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year ROIIC % calculated?
1-Year ROIIC % is calculated from a company's financial statements. For Agilent Technologies (MEX:A), the current 1-Year ROIIC % is 33.33 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Agilent Technologies (MEX:A) Overvalued in 2026?
Based on GuruFocus' analysis, Agilent Technologies stock appears to be undervalued.
The current stock price of MXN2,350.00 is trading 8.1% below its estimated GF Value™ of MXN2,557.40.
GuruFocus considers Agilent Technologies to be Fairly Valued.
Key valuation signals for MEX:A:
1-Year ROIIC %: 33.33
GF Value™: MXN2,557.40 vs. price of MXN2,350.00 (8.1% below fair value)
Industry Position: 951.4% above the Medical Diagnostics & Research median (#58 of 206)
No single metric tells the full story. See the MEX:A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
89GF Score
Get the complete analysis for MEX:A
1-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:A has been successfully added to your 
